Literature DB >> 19080746

Extending the time frame for emergency intravenous thrombolytic therapy for treatment of acute ischemic stroke.

Harold P Adams.   

Abstract

Entities:  

Year:  2009        PMID： 19080746     DOI： 10.1007/s11910-009-0001-1

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN： 1528-4042            Impact factor:   5.081


× No keyword cloud information.
  5 in total

1.  Measurement of the ischemic penumbra with MRI: it's about time.

Authors:  Steven Warach
Journal:  Stroke       Date:  2003-09-11       Impact factor: 7.914

2.  Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study.

Authors:  Gregory W Albers; Vincent N Thijs; Lawrence Wechsler; Stephanie Kemp; Gottfried Schlaug; Elaine Skalabrin; Roland Bammer; Wataru Kakuda; Maarten G Lansberg; Ashfaq Shuaib; William Coplin; Scott Hamilton; Michael Moseley; Michael P Marks
Journal:  Ann Neurol       Date:  2006-11       Impact factor: 10.422

3.  Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset.

Authors:  Anthony J Furlan; Dirk Eyding; Gregory W Albers; Yasir Al-Rawi; Kennedy R Lees; Howard A Rowley; Christian Sachara; Mariola Soehngen; Steven Warach; Werner Hacke
Journal:  Stroke       Date:  2006-03-30       Impact factor: 7.914

4.  The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.

Authors:  Werner Hacke; Greg Albers; Yasir Al-Rawi; Julien Bogousslavsky; Antonio Davalos; Michael Eliasziw; Michael Fischer; Anthony Furlan; Markku Kaste; Kennedy R Lees; Mariola Soehngen; Steven Warach
Journal:  Stroke       Date:  2004-11-29       Impact factor: 7.914

5.  Evolving paradigms in neuroimaging of the ischemic penumbra.

Authors:  Chelsea S Kidwell; Jeffry R Alger; Jeffrey L Saver
Journal:  Stroke       Date:  2004-10-07       Impact factor: 7.914
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.